申请人:The Dow Chemical Company
公开号:US04343808A1
公开(公告)日:1982-08-10
Method for inhibiting the sickling of sickle erythrocytes in blood by contacting the sickle erythrocytes with a compound of the formula: ##STR1## or a pharmaceutically-acceptable salt thereof wherein X represents sulfur, oxygen or imino; and R.sub.m and R.sub.p each independently represent hydrogen, cyano, nitro, alkylthio, alkylsulfinyl, alkylsulfonyl, alkyl or trifluoromethyl.
通过将镰刀红细胞与以下公式的化合物接触,抑制血液中的镰刀红细胞变形:##STR1## 或其药学上可接受的盐,其中X代表硫、氧或亚硝基;R.sub.m 和 R.sub.p 各自独立地代表氢、氰基、硝基、烷基硫、烷基亚硫酰基、烷基磺酰基、烷基或三氟甲基。